Maryland to Track Opioid Settlement Funds from Purdue Pharma
The latest in this situation
How it started
What happened
Maryland is implementing a new dashboard to track nearly $750 million in settlement money received from opioid manufacturers and distributors, including Purdue Pharma and CVS. The state aims to provide transparency on how these funds are spent down to local counties and municipalities. Lieutenant Governor Aruna Miller stated that 70% of the funds will go directly to local jurisdictions. The state has already received about $250 million, with the remainder expected over the next 10 to 15 years.
From wypr.org
Why it matters
The settlement funds are designated for local strategies such as prevention, treatment, recovery, and harm reduction in underserved areas. This allocation of public funds directly impacts local public health spending and resource distribution within Maryland.
From wypr.org
Who's involved
- MarylandState of Maryland receiving and stewarding the opioid settlement funds.
- Purdue PharmaOpioid manufacturer contributing to the settlement funds.
How it developed
Newest first. Tap a step to see who reported it.- Annapolis set criteria for the Opioid Restitution Fund on November 2, 2026.Sub-event
- Maryland and the Maryland Department of Health jointly fund the behavioral and health care needs.Sub-event
- Lt. Gov. Aruna Miller coordinates the office response to the opioid crisis in Maryland.Sub-event
State officials in Maryland are reviewing opioid settlement funds and local needs.1 source
Keep exploring
The entities involved
-
Maryland
state of the United States of America
-
Purdue Pharma
American Pharmaceuticals Company